Immune Biosolutions is a clinical-stage biotech company based in Sherbrooke, Quebec, specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. The company's cutting-edge techniques, including phage display and single B cell screening technologies, enable the engineering of custom-fit immunotherapeutic agents. Immune Biosolutions also offers its biomanufacturing capacity in a fee-for-service model and has several discovery programs for various cancer and infectious disease indications in its internal pipeline.

IMMU

COM:IMMUNEBIOSOLUTIONS

Immune Biosolutions